PPAR-γ agonists inhibit production of monocyte inflammatory cytokines

Nature

Volumn 391, Issue 6662, 1998, Pages 82-86

  Jiang, Chengyu ^a   Ting, Adrian T ^a   Seed, Brian ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FENOPROFEN; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN J2; TROGLITAZONE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CHROMANS; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; LEUKOCYTES, MONONUCLEAR; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN D2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031888958     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/34184     Document Type: Article

References (28)

1. Mangelsdorf, D. J. et al. The nuclear receptor superfamily: the second decade. Cell 83, 835-839 (1993).
2. Lemberger, T., Desvergne, B. & Wahli, W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol. 12, 335-363 (1996).
3. Chawla, A., Schwarz, E. J., Dimaculangan, D. D. & Lazar, M. A. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135, 798-800 (1994).
4. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. & Spiegelman, B. M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234(1994).
5. Tontonoz, P., Hu, E. & Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79, 1147-1156 (1994).
6. Hu, E., Tontonoz, P. & Spiegelman, B. M. Transdifferentiation by myoblasts by the adipogenic transcription factor PPAR gamma and C/EBP alpha. Proc. Natl Acad. Sci. USA 92, 9856-9860 (1995).
7. Lehmann, J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270, 12953-12956 (1995).
8. Kliewer, S. A. et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83, 813-819 (1995).
9. Forman, B. M. et al. 15-Deoxy-delta 12,14-porostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83, 803-812 (1995).
10. Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M. & Kliewer, S. A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-stereoidal anti-inflammatory drugs. J. Biol. Chem. 272, 3406-3410 (1997).
11. Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259, 87-91 (1993).
12. Patton, J. S. et al. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc. Natl Acad. Sci. USA 83, 8313-8317 (1986).
13. Torti, F. M. Torti, S. V., Larrick, J. W. & Ringold, G. M. Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta. J. Cell Biol. 108, 1105-1113 (1989).
14. Marshall, M. K., Doerrler, W., Feingold, K. R. & Grunfeld, C. Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes. Endocrinology 135, 141-147 (1994).
15. Berg, M., Fraker, D. L. & Alexander, H. R. Characterization of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes. Cytokine 6, 425-432 (1994).
16. Lang, C. H., Dobrescu, C. & Bagby, G. J. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic gluose output. Endocrinology 130, 43-52 (1992).
17. Szalkowski, D., White-Carrington, S., Berger, J. & Zhang, B. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 136, 1474-1481 (1995).
18. Braissant, O., Foufelle, F., Scotto, C., Dauca, M. & Wahli, W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137, 354-366 (1996).
19. Greene, M. E. et al. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Express. 4, 281-299 (1995).
20. Devchand, P. R. et al. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384, 39-43 (1996).
21. Yu, K. et al. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270, 23975-23983 (1995).
22. Meade, E. A. Smith, W. L. & DeWitt, D. L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268, 6610-6614 (1993).
23. Lau, C. S., Morley, K. D. & Belch, J. J. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis - a double-blind placebo controlled study. Br. J. Rheumatol. 32, 982-989 (1993).
24. Feldmann, M., Brennan, F. M. & Maini, R. N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14, 397-440 (1996).
25. Brennan, F. M. & Feldman, M. Cytokines in autoimmunity. Curr. Opin. Immunol. 8, 872-877 (1996).
26. Moreland, L. W. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med. 337, 141-147 (1997).
27. McEvoy, G. K. (ed) AHFS 97 Drug Information (American Society of Health-Systems Pharmacists, Bethesda, MD, 1997).
28. Firestein, G. S. & Zvaifler, N. J. Anticytokine therapy in rheumatoid arthritis. N. Engl. J Med. 337, 195-197 (1997).